Amarin Corp Plcuk (AMRN) Other Operating Expenses (2022 - 2026)

Amarin Corp Plcuk (AMRN) reported Other Operating Expenses of $3.1 million for Q1 2026, down 89.92% year-over-year from $31.2 million in Q1 2025, and up 105.01% quarter-over-quarter from -$62.8 million in Q4 2025.

Amarin Corp Plcuk (AMRN) Other Operating Expenses (2022 - 2026) Analysis & Trends

Amarin Corp Plcuk (AMRN) has 5 years of Other Operating Expenses data on file, last reported at $3.1 million in Q1 2026.

  • Other Operating Expenses for Q1 2026 came in at $3.1 million, down 89.92% year-over-year; the trailing twelve-month figure through Mar 2026 was -$46.0 million (down 326.74% YoY), and the FY2024 annual result was $12.6 million, down 2.75% from the prior year.
  • Other Operating Expenses advanced to $3.1 million in Q1 2026 per AMRN's latest filing, from -$62.8 million in the prior quarter.
  • Over five years, Other Operating Expenses peaked at $31.2 million in Q1 2025 and troughed at -$74.2 million in Q4 2024.
  • A 5-year average of -$3.1 million and a median of $7.9 million in 2022 frame the typical range for Other Operating Expenses.
  • The sharpest annual moves came in 2024 and 2025: Other Operating Expenses sank 673.4% in 2024, then soared 336.73% in 2025.
  • A 5-year view of Other Operating Expenses shows it stood at $12.6 million in 2022, then grew by 2.4% to $12.9 million in 2023, then slumped by 673.4% to -$74.2 million in 2024, then climbed by 15.47% to -$62.8 million in 2025, then surged by 105.01% to $3.1 million in 2026.
  • Business Quant data shows AMRN's Other Operating Expenses at $3.1 million in Q1 2026, -$62.8 million in Q4 2025, and $13.6 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Gsk 93,699,046.73 Bn 93,699,041.77 Bn 7.76 Bn
2 Eli Lilly 1,012.06 Bn 1,006.77 Bn 16.22 Bn
3 Johnson & Johnson 560.67 Bn 538.62 Bn 15.96 Bn
4 AbbVie 402.20 Bn 392.85 Bn 10.78 Bn
5 Merck 298.59 Bn 292.94 Bn 12.09 Bn
6 Amgen 188.77 Bn 176.74 Bn 5.87 Bn
7 Gilead Sciences 160.22 Bn 152.49 Bn 5.52 Bn
8 Pfizer 148.19 Bn 135.42 Bn -1.21 Bn
9 Bristol Myers Squibb 116.72 Bn 106.26 Bn 8.07 Bn
10 Amarin Corp Plcuk 5.84 Bn 5.66 Bn 17.77 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 3.14 Mn
Dec 31, 2025 -62.76 Mn
Sep 30, 2025 13.60 Mn
Mar 31, 2025 31.20 Mn
Dec 31, 2024 -74.25 Mn
Sep 30, 2024 3.12 Mn
Jun 30, 2024 29.16 Mn
Dec 31, 2023 12.95 Mn
Dec 31, 2022 12.65 Mn
Jun 30, 2022 13,000.00